OxyMem retrofits wastewater treatment plant with an MABR to reduce plant opex and defers capital expenditure

September 06, 2018 | Case Study

Wastewater treatment has benefited leaps and bound with the introduction of membrane bioreactors. The overall MBR market is around $2 billion, with growth rates north of 10%. Some wastewater markets, including parts of South America and Asian countries like China, are expected to see faster growth rates. This is largely driven by increasing access to wastewater treatment in rural and decentralized locations as well as meeting BOD/COD and nutrient discharge regulations in both municipal and high-value, low-volume industrial applications in industry. However, the next generation of bioreactors from a handful of startups are using membranes as growth media, commonly know as membrane aerated bioreactors (MABRs), which compete more directly with activated sludge and nitrification and denitrification technologies. OxyMem is among the emerging leaders in MABRs, competing with the likes of Fluence (merger betwen Emefcy and RWL) and global leader Suez Water. 

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978